ABOUT THIS EVENT

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, rings the Nasdaq Closing Bell remotely from across the country.

Richard King, M.B.A., CEO, rings the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.